| ABEMACICLIB |
Verzenio® |
Eli Lilly Australia Pty Ltd |
|
Mar 2019 |
|
| ALECTINIB |
Alecensa® |
Roche Products Pty Ltd |
|
Mar 2019 |
|
| ALIROCUMAB |
Praluent® |
sanofi-aventis Australia Pty Ltd |
|
Mar 2019 |
|
| ATEZOLIZUMAB AND BEVACIZUMAB |
|
Roche Products Pty Ltd |
|
Mar 2019 |
|
| BENZATHINE BENZYLPENICILLIN |
Bicillin L-A® |
Pfizer Australia Pty Ltd |
|
Mar 2019 |
|
| BEVACIZUMAB |
Avastin® |
Roche Products Pty Ltd |
|
Mar 2019 |
|
| BLINATUMOMAB |
Blincyto® |
Amgen Australia Pty Limited |
|
Mar 2019 |
|
| BOTULINUM TOXIN TYPE A |
Botox® |
Allergan Australia Pty Ltd |
|
Mar 2019 |
|
| BUDESONIDE |
Budenofalk® |
Orphan Australia Pty Ltd |
|
Mar 2019 |
|
| BUDESONIDE |
Entocort® |
Emerge Health Pty Ltd |
|
Mar 2019 |
|
| BUPRENORPHINE |
Sublocade® |
Indivior Pty Ltd |
|
Mar 2019 |
|
| BUPRENORPHINE |
Buvidal® |
Camurus Pty Ltd |
|
Mar 2019 |
|
| CABOZANTINIB |
Cabometyx® |
Ipsen Pty Ltd |
|
Mar 2019 |
|
| CALCIUM |
Cal-500® |
Petrus Pharmaceuticals Pty Ltd |
|
Mar 2019 |
|
| CERTOLIZUMAB PEGOL |
Cimzia® |
UCB Australia Proprietary Limited |
|
Mar 2019 |
|
| CLOSTRIDIUM BOTULINUM TYPE A TOXIN – HAEMAGGLUTININ C COMPLEX |
Dysport® |
Ipsen Pty Ltd |
|
Mar 2019 |
|
| DABRAFENIB; TRAMETINIB |
|
Novartis Pharmaceuticals Australia Pty Limited |
|
Mar 2019 |
|
| DARATUMUMAB |
Darzalex® |
Janssen-Cilag Pty Ltd |
|
Mar 2019 |
|
| DARBEPOETIN ALFA |
Aranesp® |
Amgen Australia Pty Limited |
|
Mar 2019 |
|
| DASATINIB |
Sprycel® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2019 |
|
| DRUGS FOR THE TREATMENT OF HEPATITIS C STAKEHOLDER MEETING OUTCOMES DECEMBER 2018
(VARIOUS) |
|
|
Hepatitus C |
Mar 2019 |
|
| ENOXAPARIN |
Clexane® |
sanofi-aventis Australia Pty Ltd |
|
Mar 2019 |
|
| ERENUMAB |
Aimovig® |
Novartis Pharmaceuticals Australia Pty Limited |
Chronic migraine |
Mar 2019 |
|
| EXENATIDE |
Bydureon Bcise® |
AstraZeneca Pty Ltd |
|
Mar 2019 |
|
| FLUTICASONE FUROATE + UMECLIDINIUM + VILANTEROL |
Trelegy® Ellipta® |
GlaxoSmithKline Australia Pty Ltd |
|
Mar 2019 |
|
| INFLIXIMAB |
Inflectra® |
Pfizer Australia Pty Ltd |
|
Mar 2019 |
|
| INSULIN GLARGINE WITH LIXISENATIDE |
Soliqua® |
sanofi-aventis Australia Pty Ltd |
|
Mar 2019 |
|
| IVACAFTOR |
Kalydeco® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
|
Mar 2019 |
|
| LANREOTIDE |
Somatuline® Autogel® |
Ipsen Pty Ltd |
|
Mar 2019 |
|
| LENALIDOMIDE |
Revlimid® |
Celgene Pty Limited |
|
Mar 2019 |
|
| LENALIDOMIDE |
Revlimid® |
Celgene Pty Limited |
|
Mar 2019 |
|
| LETERMOVIR |
Prevymis® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2019 |
|
| LEVONORGESTREL |
Kyleena® |
Bayer Australia Ltd |
|
Mar 2019 |
|
| MORPHINE |
Kapanol® |
Mayne Pharma International Pty Ltd |
|
Mar 2019 |
|
| NALOXONE |
Nyxoid® |
Mundipharma Pty Limited |
|
Mar 2019 |
|
| NANOPARTICLE ALBUMIN-BOUND PACLITAXEL |
Abraxane® |
Specialised Therapeutics Australia Pty Ltd |
Pancreatic cancer |
Mar 2019 |
|
| NATIONAL HEPATITIS C DATA COLLECTION (VARIOUS) |
|
|
Hepatitis C |
Mar 2019 |
|
| NERATINIB |
Nerlynx® |
Specialised Therapeutics Australia Pty Ltd |
|
Mar 2019 |
|
| NIVOLUMAB |
Opdivo® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2019 |
|
| NIVOLUMAB (MELANOMA) |
Opdivo® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2019 |
|
| OCRIPLASMIN |
Jetrea® RTU |
I-Care Pharma Distributors Pty Ltd |
|
Mar 2019 |
|
| PEGVISOMANT |
Somavert® |
Pfizer Australia Pty Ltd |
|
Mar 2019 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2019 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2019 |
|
| PERTUZUMAB |
Perjeta® |
Roche Products Pty Ltd |
|
Mar 2019 |
|
| QUADRIVALENT INFLUENZA VACCINE |
Fluarix Tetra® |
GlaxoSmithKline Australia Pty Ltd |
|
Mar 2019 |
|
| RITUXIMAB |
Truxima® |
Celltrion Healthcare Australia Pty Ltd |
|
Mar 2019 |
|
| RIVAROXABAN |
Xarelto® |
Bayer Australia Ltd |
|
Mar 2019 |
|
| SEVELAMER |
Sevelamer Dr Reddy's® |
Dr Reddy's Laboratories (Australia) Pty Ltd |
|
Mar 2019 |
|
| SODIUM PHENYLBUTYRATE |
Pheburane® |
Orpharma Pty Ltd |
|
Mar 2019 |
|
| SOMATROPIN |
- Genotropin GoQuick®
- NutropinAq®
|
- Pfizer Australia Pty Ltd
- Ipsen Pty Ltd
|
|
Mar 2019 |
|
| TEDUGLUTIDE |
Revestive® |
Shire Australia Pty Ltd |
|
Mar 2019 |
|
| TENOFOVIR WITH EMTRICITIABINE AND EFAVIRENZ; TENOFOVIR WITH EMTRICITABINE AND RILPIVIRINE;
TENOFOVIR WITH EMTRICITABINE, ELVITAGREVIR AND COBICISTAT |
- Atripla®
- Eviplera®
- Stribild®
|
Gilead Sciences Pty Limited |
|
Mar 2019 |
|
| TEZACAFTOR + IVACAFTOR (&) IVACAFTOR |
Symdeko® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
|
Mar 2019 |
|
| TEZACAFTOR + IVACAFTOR (&) IVACAFTOR |
Symdeko® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
|
Mar 2019 |
|
| TIOTROPIUM |
Braltus® |
Teva Pharma Australia Pty Ltd |
|
Mar 2019 |
|
| TIOTROPIUM |
Spiriva® |
Boehringer Ingelheim Pty Ltd |
|
Mar 2019 |
|
| TOCILIZUMAB |
Actemra® |
Roche Products Pty Ltd |
Giant cell arteritis (GCA) |
Mar 2019 |
|
| TOCILIZUMAB |
Actemra® |
Roche Products Pty Ltd |
Severe active polyarticular juvenile idiopathic arthritis (JIA) |
Mar 2019 |
|
| TOFACITINIB |
Xeljanz® |
Pfizer Australia Pty Ltd |
|
Mar 2019 |
|
| TRASTUZUMAB |
Ontruzant® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2019 |
|
| TRASTUZUMAB |
Ogivri® |
Alphapharm Pty Ltd |
|
Mar 2019 |
|
| TRIGLYCERIDES MEDIUM CHAIN FORMULA; PROTEIN FORMULA WITH CARBOHYDRATE, FAT, VITAMINS
AND MINERALS |
- Nutrini Peptisorb®
- Nutrini Peptisorb Energy®
|
Nutricia Australia Pty Limited |
|
Mar 2019 |
|